Fundraising Fox
/Companies
Sign in

NapiGen

Wilmington, US · Founded 2016 · 19 employees on LinkedIn · 7 known investors

Find your way into NapiGen

Sign up to see every warm intro you have to NapiGen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NapiGen team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.

AgTechBiotech

Investors · 7

The Innovation Spacelisted by The Innovation SpaceWilmington · $200K

How we know: The Innovation Space's portfolio page · Not right? Tell us

Grantham FoundationreportedBoston

How we know: genomeweb.com · Not right? Tell us

MarsBioreportedLos Angeles

How we know: genomeweb.com · Not right? Tell us

Also in the syndicate · 3

Breakout Labs/Thiel FoundationThrive SVG VenturesUnited Mitochondrial Disease Foundation

Funding

SEC filings, press & company announcements

$7.8M disclosed across 1 round · 2022

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

PrecigenPrecigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.
PerigenPeriGen develops software technology that identifies potential complications during childbirth to help clinicians around the world prevent avoidable harm during labor and delivery. The company serves healthcare providers and perinatal care teams globally.
PepGenPepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
NVIGENNVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
Biogen IdecBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

Companies working in the same space as NapiGen.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$225K
Department of Agriculture (USDA)Phase I2020$100K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does NapiGen do?
Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.
Who are NapiGen's investors?
NapiGen's investors include RA Capital, The Innovation Space, Grantham Foundation, MarsBio.
How much funding has NapiGen raised?
NapiGen has disclosed $7.8M raised across 1 round.
Where is NapiGen headquartered?
NapiGen is headquartered in Wilmington, US.